Back to today’s briefing

Story perspectives

Moderna and IBM Use Quantum Computing to Transform mRNA Vaccines

7/19/2025

26 2

Summary

Story summary

Moderna and IBM are revolutionizing mRNA vaccine design through quantum computing, successfully simulating a 60-nucleotide mRNA sequence with 80 qubits. By employing Conditional Value at Risk (CVaR), they aim to refine mRNA technology, paving the way for more effective vaccines that could save countless lives.

1 of 1

Story summary

Moderna and IBM are revolutionizing mRNA vaccine design through quantum computing, successfully simulating a 60-nucleotide mRNA sequence with 80 qubits. By employing Conditional Value at Risk (CVaR), they aim to refine mRNA technology, paving the way for more effective vaccines that could save countless lives.